Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis
- 1 November 1995
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 62 (2) , 153-160
- https://doi.org/10.1016/0165-5728(95)00120-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelersImmunology Today, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Role of Lymphocyte Adhesion Receptors in Transient Interactions and Cell LocomotionAnnual Review of Immunology, 1991
- T‐lymphocyte entry into the central nervous systemJournal of Neuroscience Research, 1991
- Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophagesNature, 1990
- The T Lymphocyte in Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990
- Cellular immune reactivity within the CNSTrends in Neurosciences, 1986
- Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic LesionsScience, 1983
- Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosisAnnals of Neurology, 1977